ObsEva SA to Participate in JP Morgan Healthcare Conference January 7-10, 2019
January 02, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston – January 2, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products
January 08, 2018 06:00 ET
|
Enable Injections, Inc.
CINCINNATI, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Enable Injections, Inc., developer of the advanced enFuse™ large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has...
Assembly Biosciences to Present at the J.P. Morgan Healthcare Conference
January 04, 2018 07:05 ET
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...